EDMONTON, Alberta, June 02, 2025 (GLOBE NEWSWIRE) -- Quest PharmaTech Inc. (TSX-V: QPT) (“Quest” or the “Company”), a Canadian based pharmaceutical company developing products to improve the quality of life through investee companies and proprietary technologies, today provided a corporate update and announced that it has filed its annual audited financial statements for the year ended January 31, 2025, Management’s Discussion and Analysis and related filings on SEDAR+ (www.sedarplus.ca). The Company report ...

CALGARY, Alberta, June 02, 2025 (GLOBE NEWSWIRE) -- News Release – TC Energy Corporation (TSX:TRP) (NYSE:TRP) (TC Energy) today announced that it does not intend to exercise its right to redeem its Cumulative Redeemable First Preferred Shares, Series 3 (Series 3 Shares) and Cumulative Redeemable First Preferred Shares, Series 4 (Series 4 Shares) on June 30, 2025. As a result, subject to certain conditions: (a) the holders of Series 3 Shares have the right to choose one of the following options with regard t ...

TORONTO, June 02, 2025 (GLOBE NEWSWIRE) -- Wallbridge Mining Company Limited (TSX: WM, OTCQB:WLBMF) (“Wallbridge” or the “Company”) today announced the results for the first eleven holes of its 2025 exploration drilling program at its 100% owned Martiniere gold project (“Martiniere”). The results include multiple high-grade gold intercepts along extensions to four of the zones targeted along the Bug Lake (“BL”) deformation corridor, and at a fifth newly identified target located approximately 300 metres nor ...

GRIMSBY, Ontario, June 02, 2025 (GLOBE NEWSWIRE) -- Andrew Peller Limited (ADW.A / ADW.B) (“APL” or “the Company”), one of Canada’s leading producers and marketers of quality wines, spirits, and craft beverage alcohol products, today announced that Renee Cauchi, CPA, CA, has been appointed Chief Financial Officer. Ms. Cauchi, who was named Vice President, Finance and Interim Chief Financial Officer in September 2024, has been in progressively senior finance positions with the Company since 2015, overseeing ...

Core Insights - Harvard Bioscience, Inc. has appointed John Duke to its board of directors, effective June 2, 2025, and he will also serve on the audit and nominating and governance committees [1][2] - Katherine Eade has been named Lead Independent Director of the Company's board of directors [1] - Thomas Loewald has retired from the board after serving since October 2017 [3] Company Overview - Harvard Bioscience, Inc. is a leading developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, drug and therapy discovery, bio-production, and preclinical testing for pharmaceutical development [4] - The Company serves a diverse customer base, including academic institutions, government laboratories, and leading pharmaceutical and biotechnology organizations, with operations in the United States, Europe, and China [4]

Group 1 - Adeia Inc. will participate in the "2025 Virtual Tech Conference: Discover the Innovations Reshaping Tomorrow" hosted by Maxim Group LLC from June 3rd to June 5th, with a fireside chat scheduled for June 4th at 4:00 p.m. EDT [1][2] - The conference will focus on the rapid evolution of technology and its disruptive impact across various industries, including healthcare, drones, consumer IoT, business solutions, and gaming & entertainment [2] - Discussions will highlight how emerging growth companies are leveraging Quantum Computing and Artificial Intelligence (AI) to position themselves for future growth [2] Group 2 - Maxim Group LLC is a full-service investment banking and wealth management firm that provides a comprehensive range of financial services, including investment banking and equity research [4] - Adeia Inc. is a leading R&D and intellectual property licensing company that accelerates the adoption of innovative technologies in the media and semiconductor industries [5] - Adeia's innovations are foundational to technology solutions that enhance digital entertainment and electronics, impacting millions of lives globally [5]

Core Viewpoint - Constellation Brands has announced the full redemption of its outstanding Senior Notes prior to maturity, indicating a strategic financial move to manage its debt obligations effectively [1][2]. Group 1: Redemption Details - The company will redeem all of its 4.75% Senior Notes due 2025 and 5.00% Senior Notes due 2026, with redemption dates set for July 2, 2025, and June 12, 2025, respectively [1]. - As of June 2, 2025, the total outstanding principal amount of the notes is $900.0 million [1]. Group 2: Company Overview - Constellation Brands is a prominent international producer and marketer of beer, wine, and spirits, with operations in the U.S., Mexico, New Zealand, and Italy [3]. - The company's brand portfolio includes well-known names such as Corona Extra, Modelo Especial, and Robert Mondavi Winery, among others [3].

Core Viewpoint - Altai Resources Inc. has completed the repositioning of its Canadian investment portfolio to enhance liquidity and eliminate equity market risk [1][2]. Group 1: Repositioning Details - The repositioning involved the sale of all marketable securities and reinvestment of net cash proceeds into cash and cash equivalents [1]. - The total market value of the newly structured Investment Portfolio is approximately $3.9 million [2]. - The market value of the Investment Portfolio per common share is approximately $0.07, based on 56,033,552 issued and outstanding common shares [2]. Group 2: Company Overview - Altai Resources Inc. is based in Toronto, Ontario, and has a producing oil property in Alberta and an exploration gold property in Quebec [3]. - The company’s investment portfolio is now entirely comprised of cash and cash equivalents [2].

ATLANTA, GA., June 02, 2025 (GLOBE NEWSWIRE) -- Americold, a global leader in temperature-controlled storage, logistics and facilities solutions, and value-added services, today announced a series of executive leadership appointments. These changes are part of the company’s ongoing strategy to enhance operational execution, deepen customer relationships, and unlock global growth opportunities. Americold has created a new executive role, President, and appointed Rob Chambers to the position. In this capacit ...

BOSTON, June 02, 2025 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (Nasdaq: TRDA) today announced that the Company granted an aggregate of 23,820 restricted stock units (“RSUs”) to six newly-hired non-executive employees under the Company’s 2025 Inducement Equity Plan (the “Inducement Plan”), effective as of June 1, 2025. The inducement grants were previously approved by the Compensation Committee of the Company’s Board of Directors, as a material inducement to the new employees’ entry into employment wit ...